Cargando…
B Cell Signaling and Activation in Autoimmunity
Autores principales: | Hendriks, Rudi W., Corneth, Odilia B. J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9914404/ https://www.ncbi.nlm.nih.gov/pubmed/36766841 http://dx.doi.org/10.3390/cells12030499 |
Ejemplares similares
-
Aberrant B Cell Signaling in Autoimmune Diseases
por: Corneth, Odilia B. J., et al.
Publicado: (2022) -
Targeting Bruton’s Tyrosine Kinase in Inflammatory and Autoimmune Pathologies
por: Neys, Stefan F. H., et al.
Publicado: (2021) -
Bruton’s Tyrosine Kinase Inhibition as an Emerging Therapy in Systemic Autoimmune Disease
por: Neys, Stefan F. H., et al.
Publicado: (2021) -
Toll-Like Receptor Signaling Drives Btk-Mediated Autoimmune Disease
por: Rip, Jasper, et al.
Publicado: (2019) -
Decreased BAFF Receptor Expression and Unaltered B Cell Receptor Signaling in Circulating B Cells from Primary Sjögren’s Syndrome Patients at Diagnosis
por: Neys, Stefan F. H., et al.
Publicado: (2022)